Severity and medical consumption of new RRIs reported in the follow-up questionnaires
| Total | Intervention group | Control group | |
| (n=1250) | (n=618) | (n=632) | |
| Pain score of RRI | |||
| Rest (NRS, 0–10)∆ | 2.4 (2.3) | 2.3 (2.3) | 2.5 (2.3) |
| Running (NRS, 0–10)∆ | 4.1 (2.8) | 4.0 (2.8) | 4.2 (2.8) |
| Use of painkillers and/or NSAIDs | 198 (15.8) | 88 (14.2) | 110 (17.4) |
| Treatment of health professional | 548 (43.8) | 265 (42.9) | 283 (44.8) |
| Physiotherapist | 517 (41.4) | 248 (40.1) | 269 (42.6) |
| General practitioner | 52 (4.2) | 27 (4.4) | 25 (4.0) |
| Medical specialist | 48 (3.8) | 19 (3.1) | 29 (4.6) |
Categorical data are presented as n (%) and continuous data (∆) as means (SD). No statistically significant differences between intervention and control group.
NRS, numeric rating scale; NSAIDs, non-steroidal anti-inflammatory drugs; RRI, running-related injury.